Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Veradermics Incorporated (MANE) had Free Cash Flow per Share of $-96.14 for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-83.37M |
|
-- |
|
-- |
|
$72.35M |
|
$-72.35M |
|
$2.35M |
|
$-70.00M |
|
$-70.00M |
|
$-70.00M |
|
$-70.00M |
|
$-70.00M |
|
$-70.00M |
|
$-72.35M |
|
$-72.35M |
|
0.74M |
|
0.74M |
|
$-111.91 |
|
$-111.91 |
|
| Balance Sheet Financials | |
$152.49M |
|
$0.02M |
|
$0.12M |
|
$152.62M |
|
$9.15M |
|
-- |
|
$264.48M |
|
$273.63M |
|
$-121.01M |
|
$-121.01M |
|
$-121.01M |
|
0.75M |
|
| Cash Flow Statement Financials | |
$-71.60M |
|
$-118.86M |
|
$159.14M |
|
$53.08M |
|
$21.77M |
|
$-31.32M |
|
$1.44M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-71.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
57.84% |
|
57.84% |
|
-45.86% |
|
57.84% |
|
$-162.00 |
|
|
Free Cash Flow per Share |
$-96.14 |
$-96.11 |
|